Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients

BACKGROUND: Hepatitis C virus (HCV)-seropositive donor hearts are underutilized for orthotopic heart transplantation (OHT). The advancement of direct-acting antiviral agent (DAA) treatment for HCV makes utilizing HCV-seropositive and viremic donor organs in HCV-seronegative recipients a possibility....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuanjia, Shudo, Yasuhiro, Lee, Roy, Woo, Y. Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307410/
https://www.ncbi.nlm.nih.gov/pubmed/32527989
http://dx.doi.org/10.12659/AOT.922723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307410/
https://www.ncbi.nlm.nih.gov/pubmed/32527989
http://dx.doi.org/10.12659/AOT.922723

Ejemplares similares